Thanks for the input. Sounds like they will have 3 products in Market faster than expected. Any novel ADHD med will sell. By next report barring market isssues, I think you see 12. Sometimes these funds can be sneaky. NEA has 25% I wonder if they would pressure a sale of the company?
Was this fast track news expected. Or baked in? I find it a pleasant surprise as it is an ADHD med and not necessarily highest of need for fast track. Personally I think the news is underplaying here.
I have held a lot of BCRX since8-9s. I like it. But right now I like SUPN more. It is going to 12. Cannot deny these reports. Better than others with no negatives only positive. Watch TRVN today having conference and has a lot going for it. Volatile and thinly traded. But will get attention. Good luck.
2 huge points.
1. Actavis is working very closely on design of trials and coordinating views towards further trials and launch. Looks very much like they are interested in signing the option.
2. If they sign the option TRVN gets close to 70mil upfront. That is nearly half the value of the current cap (upfront). This is solely based on positive phase 2 trial (pretty good odds). Then tack on royalties and many more millions in milestone payments.
With this potential value coming and the fact that the current cap under 200mil. One has to consider this very undervalued. Then throw in the fact that the FDA is not liking pain devices. It wants better pain killer than morphine, giving TRVN pain meds the green light. It gets better and better here. I have a funneling system set to accumulate shares here. There is support.
Understand your game.
It has great rev. growth and 100mil sales 2014, 3 drugs in pipeline. It has to be valued 5x revenue. 500mil/40 mil shares =12 bucks. That is giving no value of pipeline and 5x is cheap. could easily be valued at 750mil in this market. 18pps is my 1 yr target.
Dont forget about the pipeline. At about 300mil this company is severely undervalued. 100mil annual revs with high % growth. Wow. Wow. Wow. My 30k shares are looking good.
I just bought a ton of MNKD under 9. This is the same old tactic. The news on the deal will settle and then the rats will tip toe out. expect the gradual increase next few days-weeks. I am not even betting on the product.